An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

Study Identifier
P24-078
CT.gov Identifier
NCT05827887
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Migraine - General
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Confirmed diagnosis of migraine according to the ICHD-3 upon judgement of the treating physician * The patients should be naive to the designated treatment * Ability to fill an e-diary app
    Exclusion Criteria:
    * Patients who cannot be treated with UBRO or ATO according to the applicable approved label * Patients participating in a concurrent clinical interventional study or within the last 30 days * Patients who were previously treated with rimegepant will be excluded from the study

    Protocol Summary

    Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will evaluate how effective the use of ubrogepant and atogepant is in treating adult participants with migraine.

    Urogepant (Ubrelvy) and Atogepant (Qulipta) are approved drugs for treatment of migraine in adults in the US. Approximately 200 adult participants who are prescribed Ubrogepant or atogepant by their doctors will be enrolled in this study in Israel.

    Participants will receive ubrogepant oral tablets or atogepant oral tablets as prescribed by their physician. Participants will be followed for 90 days.

    There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

    Study Locations

    Location
    Status
    Location
    Edith Wolfson Medical Center /ID# 269740
    Holon, Central District, Israel, 5822012
    Status
    Not applicable
    Location
    Maccabi Healthcare Services /ID# 254171
    Kfar Saba, Central District, Israel, 4420123
    Status
    Not applicable
    Location
    Meir Medical Center /ID# 254170
    Kfar Saba, Central District, Israel, 4428164
    Status
    Not applicable
    Location
    Shaare Zedek Medical Center /ID# 254169
    Jerusalem, Jerusalem, Israel, 91031
    Status
    Not applicable
    Location
    ZIV Medical Center /ID# 257360
    Safed, Northern District, Israel, 13100
    Status
    Not applicable
    Location
    Assuta Ashdod Medical Center /ID# 260020
    Ashdod, Southern District, Israel, 7747600
    Status
    Not applicable
    Showing {first} - {last} of {total} Results